Cargando…

Determinants of diagnostic latency in Chinese people with Parkinson’s disease

BACKGROUND: Clinical diagnosis of Parkinson’s disease (PD) has always lagged behind clinical symptoms. The diagnostic latency might be influenced by many factors. The diagnostic latency of Chinese people with PD has been unknown. Here we designed this cross-sectional study with the purpose to identi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Ying, Zhu, Yingying, Luo, Yi, Han, Xun, Li, Yongsheng, Gan, Jing, Wu, Na, Xie, Anmu, Liu, Zhenguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558921/ https://www.ncbi.nlm.nih.gov/pubmed/31185934 http://dx.doi.org/10.1186/s12883-019-1323-5

Ejemplares similares

Apathy following Bilateral Deep Brain Stimulation of Subthalamic Nucleus in Parkinson's Disease: A Meta-Analysis
por: Wang, Ying, et al.
Publicado: (2018)

Prion-Like Mechanisms in Parkinson’s Disease
por: Ma, Jiangnan, et al.
Publicado: (2019)

Emerging Role of Sirtuin 2 in Parkinson’s Disease
por: Liu, Yumei, et al.
Publicado: (2020)

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
por: Xie, Anmu, et al.
Publicado: (2014)

The recommendations of Chinese Parkinson’s disease and movement disorder society consensus on therapeutic management of Parkinson’s disease
por: Chen, Shengdi, et al.
Publicado: (2016)

Longitudinal Prediction of Freezing of Gait in Parkinson's Disease: A Prospective Cohort Study
por: Zhao, Jiahao, et al.
Publicado: (2022)

Assessing impulse control behaviors in early Parkinson’s disease: a longitudinal study
por: Zhu, Xiaobo, et al.
Publicado: (2023)

Exploring the association between Cerebral small‐vessel diseases and motor symptoms in Parkinson's disease
por: Wan, Ying, et al.
Publicado: (2019)

Improvement of Subthalamic Nucleus Deep Brain Stimulation in Sleeping Symptoms in Parkinson's Disease: A Meta-Analysis
por: Zhang, Xue, et al.
Publicado: (2019)

The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats
por: Wu, Na, et al.
Publicado: (2018)

Prevalence and Clinical Features of FOG in Chinese PD Patients, a Multicenter and Cross-Sectional Clinical Study
por: Gan, Jing, et al.
Publicado: (2021)

CUB and Sushi Multiple Domains (CSMD1) Gene Polymorphisms and Susceptibilities to Idiopathic Parkinson's Disease in Northern Chinese Han Population: A Case-Control Study
por: Bai, Xinling, et al.
Publicado: (2021)

Update to the Treatment of Parkinson’s Disease Based on the Gut-Brain Axis Mechanism
por: Sun, Xiaohui, et al.
Publicado: (2022)

A survey of subjective constipation in Parkinson’s disease patients in shanghai and literature review
por: Gan, Jing, et al.
Publicado: (2018)

Repetitive transcranial magnetic stimulation alleviates glial activation through suppressing HMGB1/TLR4 pathway in a rat model of Parkinson’s disease
por: Han, Chao, et al.
Publicado: (2023)

Neurofilament light as a biomarker for motor decline in Parkinson’s disease
por: Liu, Yumei, et al.
Publicado: (2022)

Associations of striatal dopamine transporter binding with motor and non‐motor symptoms in early Parkinson's disease
por: Yang, Zhengjie, et al.
Publicado: (2023)

Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease
por: Wan, Ying, et al.
Publicado: (2017)

Zonisamide for the Treatment of Parkinson Disease: A Current Update
por: Li, Chengqian, et al.
Publicado: (2020)

Molecular Mechanisms Underlying Reciprocal Interactions Between Sleep Disorders and Parkinson’s Disease
por: Yang, Zhengjie, et al.
Publicado: (2021)

The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia
por: Yang, Liying, et al.
Publicado: (2018)

The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s disease
por: Tao, Mingzhu, et al.
Publicado: (2022)

THE SIGNIFICANCE OF LATENCY TIME IN ENZYME DETERMINATION
por: Baas-Becking, Lourens G. M.
Publicado: (1921)

L-3,4-Dihydroxyphenylalanine Recovers Circadian Rhythm Disturbances in the Rat Models of Parkinson's Disease by Regulating the D1R-ERK1/2-mTOR Pathway
por: Yang, Shuyuan, et al.
Publicado: (2021)

Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson’s Disease
por: Ma, Jiangnan, et al.
Publicado: (2022)

Relationship between mitochondrial DNA A10398G polymorphism and Parkinson's disease: a meta-analysis
por: Hua, Feifei, et al.
Publicado: (2017)

Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression
por: Dou, Kaixin, et al.
Publicado: (2022)

RAGE Silencing Ameliorates Neuroinflammation by Inhibition of p38-NF-κB Signaling Pathway in Mouse Model of Parkinson’s Disease
por: Wang, Xiaoli, et al.
Publicado: (2020)

Clinical characteristics in early Parkinson's disease with excessive daytime sleepiness: A cross‐sectional and longitudinal study
por: Liu, Yumei, et al.
Publicado: (2023)

Daytime Sleepiness and Parkinson's Disease: The Contribution of the Multiple Sleep Latency Test
por: Ataide, Marcelo, et al.
Publicado: (2014)

Parkinson's disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study
por: Li, Yuanyuan, et al.
Publicado: (2022)

Developmental Context Determines Latency of MYC-Induced Tumorigenesis
por: Beer, Shelly, et al.
Publicado: (2004)

Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation
por: Collins-McMillen, Donna, et al.
Publicado: (2018)

Determinants of coping styles of people with Parkinson’s Disease
por: Prins, Eva M., et al.
Publicado: (2023)

Multiple Evidences for Association between Cognitive Impairment and Dysglycemia in Parkinson’s Disease: Implications for Clinical Practice
por: Yang, Liu, et al.
Publicado: (2017)

Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson’s Disease
por: Trenado, Carlos, et al.
Publicado: (2017)

The Application of P300-Long-Latency Auditory-Evoked Potential in Parkinson Disease
por: Ferrazoli, Natalia, et al.
Publicado: (2021)

Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson’s disease
por: Gan, Jing, et al.
Publicado: (2014)

Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity
por: Perneczky, Robert, et al.
Publicado: (2011)

Correction: Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease
por: Trenado, Carlos, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vk9o3460im3v9cu9h061vvui1k